0

524604

ADLINE

img img img img
No Data Available

Adline Chemab Share Price Update

As of the latest trading session, ADLINE CHEM LAB LIMITED is trading at ₹11.28, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹11.28 and ₹11.28 today. Over the past year, the stock has delivered a return of 3.77%. In the last month, it has returned -5.21%.

Investment Returns

Over 1 Month -5.21% Over 3 Months -8.36% Over 6 Months -26.75% Over 1 Year 3.77%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Adline Chemab fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 6.60
  • P/E Ratio (TTM) 282.00
  • Beta -0.36
  • Book Value / share -2.75
  • Return on equity 0.00%
  • EPS (TTM) 0.04
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.06
info icon alternate text

Adline Chemab Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.03
Effective Tax Rate (%) 14.28
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit -0.07
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.05
Effective Tax Rate (%) 12.50
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.03
Effective Tax Rate (%) 16.66
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.09
Net Profit 0.21
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.04
EBITDA 0.19
Effective Tax Rate (%) -31.25
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.13
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.10
Effective Tax Rate (%) 7.69
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.45
Net Profit -0.13
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.22
EBITDA -0.07
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.30
Net Profit -0.27
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.18
Effective Tax Rate (%) 10.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.88
Net Profit -4.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -7.24
EBITDA -4.14
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.74
Operating Expense 1.39
Net Profit 0.72
Net Profit Margin (%) 97.29
Earnings Per Share (EPS) 1.23
EBITDA 1.08
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 6.33
Operating Expense 7.61
Net Profit -1.28
Net Profit Margin (%) -20.22
Earnings Per Share (EPS) -2.19
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -2.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -2.35
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.68
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.45
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.53
ROE % -10.55
ROCE % -7.40
Total Debt to Total Equity 0.83
EBITDA Margin -14.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.04
EBITDA Margin -3.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.07
Total Liabilities 0.07
Total Equity -1.49
Share Outstanding 0
Price to Book Ratio -5.20
Return on Assets (%) -175.09
Return on Capital (%) 2360.71
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 0.04
Total Liabilities 0.04
Total Equity -1.37
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -644.07
Return on Capital (%) 1998.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.06
Total Liabilities 0.06
Total Equity -1.56
Share Outstanding 0
Price to Book Ratio -2.01
Return on Assets (%) -6858.26
Return on Capital (%) 1806.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.87
Total Liabilities 4.87
Total Equity 2.64
Share Outstanding 0
Price to Book Ratio 1.45
Return on Assets (%) 14.72
Return on Capital (%) 18.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -0.15
Total Assets 5.63
Total Liabilities 5.63
Total Equity 1.93
Share Outstanding 0
Price to Book Ratio 1.55
Return on Assets (%) -22.77
Return on Capital (%) -28.96
Particulars MAR 2025 (Values in Cr)
Net Income -0.20
Cash from Operations -0.32
Cash from Investing 0.00
Cash from Financing 0.24
Net change in Cash 0.02
Free Cash Flow -0.32
Particulars MAR 2024 (Values in Cr)
Net Income -0.30
Cash from Operations -0.16
Cash from Investing 0.00
Cash from Financing 0.14
Net change in Cash -0.01
Free Cash Flow -0.16
Particulars MAR 2023 (Values in Cr)
Net Income -4.23
Cash from Operations 0.01
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow 0.01
Particulars MAR 2022 (Values in Cr)
Net Income 0.71
Cash from Operations 0.21
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow 0.21
Particulars MAR 2021 (Values in Cr)
Net Income -1.28
Cash from Operations -0.29
Cash from Investing 0.11
Cash from Financing -0.03
Net change in Cash -0.20
Free Cash Flow -0.28
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.19 15.23 1.82 269.67 23.12 41.00
BLISS GVS PHARMA LTD. 262.60 25.11 2.45 2778.02 105.05 277.80
CIPLA LTD 1294.75 22.00 3.17 104587.66 1165.55 1672.20
FERMENTA BIOTECH LTD. 319.05 10.61 2.40 939.00 252.15 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2473.05 41.65 24.53 41894.96 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.19 33.84 4.90 269.67 23.12 41.00
AMRUTANJAN HEALTH CARE LTD. 575.55 28.78 4.86 1663.95 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8501.75 102.17 26.60 21254.38 7630.00 10653.05
BLISS GVS PHARMA LTD. 262.60 35.78 2.51 2778.02 105.05 277.80

Adline Chemab shareholding pattern

Holding
74.14%
25.85%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Adline Chemab Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
11.28 4.93 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 11.60
  • 26 Days 12.20
  • 10 Days 12.10
  • 50 Days 12.70
  • 12 Days 12.20
  • 100 Days 13.70
  • 20 Days 12.20
  • 200 Days 14.60
11.28 PIVOT
First Support 11.28 First Resistance 11.28 Second Support 11.28 Second Resistance 11.28 Third Support 11.28 Third Resistance 11.28
RSI 43.30 ADX 60.88 MACD -0.05 Williams % R -88.79 Commodity Channel Index (CCI) -87.16
Date 2026-04-20 Week 133.00 Same Day 100.00 Month 125.00
1 Year -0.37 3 Year 0.17
Over 1 Month
-5.21% down
Over 1 Year
3.77% down
Over 3 Months
-8.36% down
Over 3 Years
27.83% down
Over 6 Months
-26.75% down
Over 5 Years
16.08% down

Adline Chemab Corporate Actions

Top Gainers

Top Losers

Adline Chemab Share Price

Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The Company name was changed from Kamron Laboratories Limited' to Adline Chem Lab Limited effective on October 13, 2021. Adline is a dynamic and innovative multinational company specializing in providing integrated solutions and services across diverse industries. It is engaged in manufacturing of pharmaceutical chemicals, fine chemicals, agrochemical products. ADLINE's mission is to revolutionize the industries it serves by providing unparalleled excellence in chemicals, laboratory and lab products establishment, active pharmaceutical ingredients (API), pharmaceuticals, agro/agro trade, biotech, and fertilizers.

In May 1990, the Company started production at its site in Rakanpur, Gujarat. Initially, the Company was manufacturing tablets, capsules and liquid orals. In 1993, it started manufacture of injections.

At present, the company is marketing its products in many states of India and also exporting to a few countries. But over the period of last three decades, there were major changes in the manufacturing technology and building layout due to which the company's plant became obsolete. After taking shareholders approval, the company had discontinued the production in 2019 and sold its land and building in December 2019.

Currently the company is continuing the marketing activities and getting its products manufactured from various manufacturers.

Mr. Hemant A. Parikh acquired the shares of the Company via Open Offer process in October, 2023 and has become the Promoter of the Company in 2024.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Adline Chem Lab Ltd?

Answer Field

Adline Chem Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 11.28 as on Apr 20 2026 12:00 AM.

What is the Market Cap of Adline Chem Lab Ltd Share?

Answer Field

The market cap of Adline Chem Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 6.60 as on Apr 20 2026 12:00 AM.

What is the 52 Week High and Low of Adline Chem Lab Ltd?

Answer Field

The 52 Week High and Low of Adline Chem Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 19.08 and ₹ 7.60.

What is 1 year return for Adline Chem Lab Ltd?

Answer Field

The 1 year returns on the stock has been 3.77%.

What is the P/E Ratio of Adline Chem Lab Ltd Share?

Answer Field

As on Apr 20 2026 12:00 AM the price-to-earnings (PE) ratio for Adline Chem Lab Ltd share is 282.00.

What is the PB ratio of Adline Chem Lab Ltd Share?

Answer Field

As on Apr 20 2026 12:00 AM, the price-to-book (PB) ratio for Adline Chem Lab Ltd share is -2.75.

How to Buy Adline Chem Lab Ltd Share?

Answer Field

You can trade in Adline Chem Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Adline Chem Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Adline Chem Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Adline Chem Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|